** Citi highlights dairy co The A2 Milk Company ATM.NZ, A2M.AX for potential growth, following positive indicators from peer Health and Happiness (H&H) International's 1112.HK full-year results
** Says H&H's report suggests industry volume declines in the super premium segment have stabilised towards year-end, possibly reflecting the strong 2024 birth rate
** Citi emphasises significance of these results for ATM's premium Genesis line, which should benefit from potentially less price-competitive market environment
** Maintains "buy" rating; ASX-listed shares' PT of A$8.20
** ATM up 36.8% YTD
(Reporting by Kumar Tanishk and Nikita Maria Jino in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com; X: @thatstanishk http://www.x.com/thatstanishk))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.